129 related articles for article (PubMed ID: 17355553)
1. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
Raghavendra S; Nair MD; Chemmanam T; Krishnamoorthy T; Radhakrishnan VV; Kuruvilla A
Eur J Neurol; 2007 Mar; 14(3):309-14. PubMed ID: 17355553
[TBL] [Abstract][Full Text] [Related]
2. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
[TBL] [Abstract][Full Text] [Related]
3. Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis.
Matsuda M; Kishida D; Kinoshita T; Hineno A; Shimojima Y; Fukushima K; Ikeda S
Intern Med; 2011; 50(19):2219-22. PubMed ID: 21963744
[TBL] [Abstract][Full Text] [Related]
4. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis.
Worthley SG; McNeil JD
J Rheumatol; 1995 Feb; 22(2):335-7. PubMed ID: 7738959
[TBL] [Abstract][Full Text] [Related]
5. Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis.
Yu T; Yang C
Z Rheumatol; 2024 May; 83(4):297-302. PubMed ID: 37755473
[TBL] [Abstract][Full Text] [Related]
6. Leukoencephalopathy due to oral methotrexate.
González-Suárez I; Aguilar-Amat MJ; Trigueros M; Borobia AM; Cruz A; Arpa J
Cerebellum; 2014 Feb; 13(1):178-83. PubMed ID: 24068485
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-related leukoencephalopathy without radiation therapy: distribution of brain lesions and pathological heterogeneity on two autopsy cases.
Matsubayashi J; Tsuchiya K; Matsunaga T; Mukai K
Neuropathology; 2009 Apr; 29(2):105-15. PubMed ID: 18627488
[TBL] [Abstract][Full Text] [Related]
8. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.
Matsumoto K; Takahashi S; Sato A; Imaizumi M; Higano S; Sakamoto K; Asakawa H; Tada K
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):913-8. PubMed ID: 7607965
[TBL] [Abstract][Full Text] [Related]
9. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
10. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Braun J; Kästner P; Flaxenberg P; Währisch J; Hanke P; Demary W; von Hinüber U; Rockwitz K; Heitz W; Pichlmeier U; Guimbal-Schmolck C; Brandt A;
Arthritis Rheum; 2008 Jan; 58(1):73-81. PubMed ID: 18163521
[TBL] [Abstract][Full Text] [Related]
12. Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis.
Abe K; Mitsuka T; Kanamori S; Yamashita K; Yamaoka A
Mod Rheumatol; 2007; 17(6):511-3. PubMed ID: 18084706
[TBL] [Abstract][Full Text] [Related]
13. Posterior reversible encephalopathy syndrome and oral methotrexate.
Hart C; Kinney MO; McCarron MO
Clin Neurol Neurosurg; 2012 Jul; 114(6):725-7. PubMed ID: 22225972
[No Abstract] [Full Text] [Related]
14. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE;
Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of subcutaneous versus oral methotrexate in active rheumatoid arthritis.
Islam MS; Haq SA; Islam MN; Azad AK; Islam MA; Barua R; Hasan MM; Mahmood M; Safiuddin M; Rahman MM; Osmany MF; Bari N; Rumki RS; Rashid FB
Mymensingh Med J; 2013 Jul; 22(3):483-8. PubMed ID: 23982537
[TBL] [Abstract][Full Text] [Related]
16. [A case of rheumatoid arthritis associated with autoimmune hemolytic anemia due to weekly low-dose methotrexate therapy].
Yoshida K; Kurosaka D; Ozawa Y; Yokoyama T; Tajima N
Ryumachi; 2000 Aug; 40(4):693-8. PubMed ID: 11021173
[TBL] [Abstract][Full Text] [Related]
17. Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.
Boogerd W; vd Sande JJ; Moffie D
J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1277-83. PubMed ID: 3225584
[TBL] [Abstract][Full Text] [Related]
18. Noncardiogenic pulmonary edema in low-dose oral methotrexate therapy.
Iikuni N; Iwami S; Kasai S; Tokuda H
Intern Med; 2004 Sep; 43(9):846-51. PubMed ID: 15497523
[TBL] [Abstract][Full Text] [Related]
19. [Adverse effects of low-dose methotrexate therapy in rheumatoid arthritis].
Furuya T; Totokawa S; Nakajima A; Suzuki T; Kashiwazaki S
Ryumachi; 1996 Oct; 36(5):746-52. PubMed ID: 8969553
[TBL] [Abstract][Full Text] [Related]
20. Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter.
Laxmi SN; Takahashi S; Matsumoto K; Higano S; Kurihara N; Imaizumi M; Abe K; Itoyama Y; Sakamoto K
Radiat Med; 1996; 14(6):303-7. PubMed ID: 9132810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
